RTI Biologics, Inc. (RTIX)

[surf1944]

8:02AM RTI Biologics beats by $0.01, beats on revs; guides Q1 slightly below consensus; guides FY12 EPS slightly below consensus and revs in-line (RTIX) 3.99 : Reports Q4 (Dec) earnings of $0.04 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.03; revenues fell 5.5% year/year to $42.9 mln vs the $41.22 mln consensus. Co sees Q1 EPS of ~$0.03 vs. $0.04 Capital IQ Consensus Estimate; sees Q1 revs of $41-42 mln vs. $42.64 mln Capital IQ Consensus Estimate. Co sees FY12 EPS of $0.15-0.17 vs. $0.19 Capital IQ Consensus Estimate; sees FY12 revs of $174-176 mln vs. $175.85 mln Capital IQ Consensus Estimate